Foresite Closes $900m Fund VI As Financial Condition Rebound Begins
Fund V In 2020 Totaled $969m, Now Fully Invested
Foresite Capital already has invested in multiple high-profile therapeutics firms with its sixth fund, including private Xaira, newly public CG Oncology, and Alumis, which is on the verge of an IPO.
